Published in Blood Weekly, May 24th, 2001
"Regulation of apoptotic cell death is being increasingly recognized as mechanisms by which cytostatic agents mediate tumor cell death," explained Eckhart Weidmann and colleagues. "Preliminary clinical studies with bendamustine, an alkylating agent with a purine nucleus, provide strong evidence that this drug is a highly effective cytostatic in low grade lymphomas."
While bendamustine does have synergistic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.